0,909  0,004  Teratogen
0,907  0,004  Embryotoxic
0,896  0,004  TNF expression inhibitor
0,891  0,003  UDP-glucuronosyltransferase substrate
0,855  0,006  CYP3A4 substrate
0,854  0,009  Antiinflammatory
0,842  0,004  Cardiovascular analeptic
0,827  0,005  Carcinogenic
0,823  0,003  Diuretic
0,822  0,005  Respiratory analeptic
0,819  0,002  Anesthetic general
0,818  0,002  UGT1A4 substrate
0,816  0,004  Sensitization
0,785  0,004  NOS3 expression inhibitor
0,774  0,003  Sulfotransferase substrate
0,762  0,004  CYP2C19 inhibitor
0,753  0,002  Androgen antagonist
0,753  0,006  Analeptic
0,732  0,003  Hair growth stimulant
0,724  0,001  Glucose-6-phosphate dehydrogenase inhibitor
0,714  0,001  UGT2B4 substrate
0,718  0,011  CYP2C9 substrate
0,708  0,002  UGT2B15 substrate
0,713  0,007  Cholesterol antagonist
0,706  0,002  Aromatase inhibitor
0,704  0,003  Prostatic (benign) hyperplasia treatment
0,690  0,003  Endometrios treatment
0,694  0,021  Transcription factor NF kappa B inhibitor
0,669  0,005  Antipruritic, allergic
0,662  0,004  Anesthetic
0,656  0,003  Contraceptive
0,639  0,002  Contraceptive female
0,632  0,002  UGT2B7 substrate
0,617  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,611  0,001  UGT2B9 substrate
0,614  0,010  AR expression inhibitor
0,616  0,013  Antiallergic
0,601  0,001  Aldosterone antagonist
0,596  0,005  CYP3A4 inhibitor
0,623  0,044  Apoptosis agonist
0,554  0,003  Prostate disorders treatment
0,565  0,015  Proliferative diseases treatment
0,545  0,003  Lipocortins synthesis antagonist
0,545  0,004  Antiacne
0,555  0,020  Immunosuppressant
0,535  0,001  UGT2B10 substrate
0,549  0,024  Prostate cancer treatment
0,534  0,012  Cardiodepressant
0,531  0,023  Antihypercholesterolemic
0,522  0,018  UGT1A9 substrate
0,489  0,003  Antipruritic, non-allergic
0,478  0,023  Apoptosis antagonist
0,454  0,002  Progesterone antagonist
0,457  0,010  Muscle relaxant
0,478  0,031  CYP2C19 substrate
0,443  0,003  Alcohol dehydrogenase substrate
0,447  0,009  Interferon gamma antagonist
0,445  0,010  Abortion inducer
0,456  0,024  NOS2 expression inhibitor
0,455  0,025  Mutagenic
0,433  0,003  Cushing's syndrome treatment
0,432  0,004  Antiinfertility, female
0,442  0,015  Sedative
0,484  0,058  Antineoplastic (breast cancer)
0,430  0,007  Skeletal muscle relaxant
0,432  0,010  Sodium/bile acid cotransporter inhibitor
0,424  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,424  0,005  UGT2B1 substrate
0,416  0,006  Antipruritic
0,429  0,020  UGT1A6 substrate
0,429  0,022  Nitric oxide antagonist
0,406  0,002  5-Alpha-reductase inhibitor
0,442  0,038  Bone diseases treatment
0,432  0,032  Antineoplastic (brain cancer)
0,472  0,072  Caspase 9 stimulant
0,401  0,002  5-Alpha-reductase 1 inhibitor
0,408  0,015  P-glycoprotein inhibitor
0,415  0,023  Interleukin 2 agonist
0,417  0,034  Cytotoxic
0,415  0,035  ICAM1 expression inhibitor
0,413  0,033  Antineoplastic (glioma)
0,396  0,028  Antineoplastic (glioblastoma multiforme)
0,402  0,037  Antiosteoporotic
0,366  0,002  5-Alpha-reductase 2 inhibitor
0,375  0,011  Antialcoholic
0,366  0,005  Contraceptive male
0,404  0,043  Antineoplastic (ovarian cancer)
0,399  0,040  CYP1A2 substrate
0,378  0,019  UGT1A1 substrate
0,366  0,008  Toxic, respiratory center
0,353  0,003  Mineralocorticoid receptor antagonist
0,347  0,001  UGT2B11 substrate
0,356  0,011  NOS3 expression enhancer
0,345  0,003  Androgen agonist
0,344  0,004  Menstruation disorders treatment
0,382  0,049  Hepatic disorders treatment
0,329  0,008  Psychosexual dysfunction treatment
0,332  0,017  UGT1A3 substrate
0,313  0,001  Arachidonic acid antagonist
0,318  0,010  Aldehyde dehydrogenase inhibitor
0,312  0,004  Postmenopausal disorders treatment
0,319  0,014  Neurotrophic factor enhancer
0,338  0,036  Chemopreventive
0,337  0,040  Antineoplastic (renal cancer)
0,298  0,003  Premenstrual syndrome treatment
0,298  0,005  Choleretic
0,315  0,025  Hepatoprotectant
0,300  0,011  Cholesterol synthesis inhibitor
0,284  0,002  Progesterone agonist
0,344  0,066  Immunostimulant
0,332  0,059  Antineoplastic (melanoma)
0,299  0,029  Eye irritation, high
0,327  0,058  CTGF expression inhibitor
0,279  0,021  Growth factor agonist
0,290  0,039  Antineoplastic enhancer
0,320  0,071  CYP2D6 substrate
0,244  0,002  RNA-directed RNA polymerase stimulant
0,267  0,026  Skin irritative effect
0,244  0,009  Estrogen antagonist
0,257  0,023  Antiviral (Influenza A)
0,229  0,002  Anabolic
0,244  0,019  Antifungal enhancer
0,226  0,003  Glucocorticoid antagonist
0,263  0,041  Antiviral (Influenza)
0,226  0,009  Growth stimulant
0,216  0,006  Tocolytic
0,288  0,093  Antineoplastic (endocrine cancer)
0,305  0,112  CYP2C9 inhibitor
0,275  0,081  Antineoplastic (multiple myeloma)
0,285  0,095  Antihypertensive
0,190  0,002  Postcoital contraceptive
0,202  0,021  Carcinogenic, group 2B
0,278  0,097  Mood disorders treatment
0,241  0,062  Antihypotensive
0,177  0,002  Glucocorticoid agonist
0,196  0,023  Farnesoid X receptor antagonist
0,269  0,097  Caspase 3 stimulant
0,209  0,038  Protein kinase stimulant
0,256  0,089  Spasmolytic
0,231  0,065  Antiparkinsonian, rigidity relieving
0,190  0,025  Antieczematic
0,169  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,217  0,052  Male reproductive disfunction treatment
0,165  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,237  0,079  Antineoplastic (liver cancer)
0,160  0,004  Na+ K+ transporting ATPase inhibitor
0,156  0,002  Lipocortins synthesis agonist
0,156  0,005  Anticholelithogenic
0,241  0,091  Chemoprotective
0,194  0,044  Lipid peroxidase inhibitor
0,202  0,053  LDLR expression enhancer
0,172  0,024  Pregnane X receptor agonist
0,225  0,079  Cytostatic
0,224  0,082  Angiogenesis stimulant
0,142  0,000  Transcortin receptor antagonist
0,186  0,047  Melanin inhibitor
0,236  0,098  Lipoprotein disorders treatment
0,144  0,006  Estradiol 17 beta-dehydrogenase inhibitor
0,147  0,011  Estrogen agonist
0,134  0,001  Corticosteroid-like
0,133  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,162  0,038  Adenylate cyclase inhibitor
0,141  0,018  Estrogen receptor beta antagonist
0,230  0,111  Antiepileptic
0,157  0,039  Liver cirrhosis treatment
0,179  0,062  Antimutagenic
0,130  0,015  Estrogen receptor alpha antagonist
0,217  0,103  Antioxidant
0,173  0,061  Interleukin 6 antagonist
0,214  0,106  Antineoplastic (sarcoma)
0,191  0,085  Psychostimulant
0,238  0,133  Antineoplastic (lung cancer)
0,222  0,117  Gastrin inhibitor
0,107  0,004  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,120  0,018  Glycine receptor antagonist
0,149  0,049  DNA polymerase I inhibitor
0,114  0,014  Glycine receptor agonist
0,203  0,103  Aldehyde oxidase inhibitor
0,193  0,096  VCAM1 expression inhibitor
0,111  0,017  Narcotic antagonist
0,173  0,079  Antirickettsial
0,137  0,043  SULT1A1 substrate
0,104  0,011  Estrogen receptor beta agonist
0,115  0,025  Bile acid receptor antagonist
0,125  0,037  Antineoplastic antibiotic
0,083  0,005  Pregnane X receptor antagonist
0,112  0,036  SULT1E1 substrate
0,097  0,021  Dysmenorrhea treatment
0,079  0,005  Hypogonadism treatment
0,082  0,011  Estrogen receptor alpha agonist
0,106  0,036  Topoisomerase II alpha inhibitor
0,083  0,013  Heme oxygenase stimulant
0,154  0,086  Muscular dystrophy treatment
0,073  0,005  Estrone sulfatase inhibitor
0,123  0,057  Microtubule formation inhibitor
0,145  0,082  Antiviral (Herpes)
0,092  0,033  CDC25A inhibitor
0,181  0,126  Tumour necrosis factor alpha release inhibitor
0,231  0,175  Antiobesity
0,077  0,023  Andropause treatment
0,173  0,120  Antineoplastic (lymphoma)
0,136  0,085  Genotoxic
0,126  0,076  Antihemorrhagic
0,077  0,029  SULT2A1 substrate
0,058  0,011  GABA uptake inhibitor
0,167  0,122  Antiglaucomic
0,179  0,136  DNA damaging
0,063  0,020  Anesthetic inhalation
0,194  0,153  Antifungal
0,193  0,152  Antidepressant
0,096  0,056  ABCA1 expression enhancer
0,114  0,074  Carcinogenic, group 3
0,119  0,080  Antihyperlipoproteinemic
0,107  0,069  GABA receptor agonist
0,064  0,029  GABA receptor antagonist
0,177  0,142  Interleukin agonist
0,173  0,138  Vascular (periferal) disease treatment
0,095  0,062  Posttraumatic stress disorder treatment
0,159  0,126  Pneumotoxic
0,110  0,078  Alkylator
0,046  0,014  Cholesterol absorption inhibitor
0,123  0,091  Antiparkinsonian, tremor relieving
0,133  0,104  Ca2+-transporting ATPase inhibitor
0,089  0,061  Actinic keratosis treatment
0,078  0,051  Keratolytic
0,027  0,002  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,244  0,219  Cyclophilin D inhibitor
0,244  0,219  Antidiabetic
0,083  0,059  Estrogen-related receptor beta agonist
0,056  0,034  GABA A receptor antagonist
0,157  0,136  Antineoplastic (cervical cancer)
0,084  0,063  Ornithine decarboxylase inhibitor
0,087  0,067  Antineoplastic, alkylator
0,181  0,163  Antihypoxic
0,101  0,084  Antitussive
0,125  0,108  Sigma receptor agonist
0,018  0,005  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,090  0,077  Glutathione S-transferase substrate
0,157  0,144  Antineoplastic (non-small cell lung cancer)
0,158  0,148  VEGF expression inhibitor
0,169  0,159  Antineoplastic (pancreatic cancer)
0,023  0,015  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,022  0,015  Vitamin D receptor antagonist
0,032  0,027  Antihyperaldosteronism
0,155  0,151  Acute neurologic disorders treatment
0,072  0,071  Opioid kappa receptor antagonist
0,026  0,025  Hedgehog signaling activator

